Entrada Therapeutics
TRDA
#6879
Rank
โ‚น43.28 B
Marketcap
โ‚น1,157
Share price
0.83%
Change (1 day)
-9.26%
Change (1 year)

P/S ratio for Entrada Therapeutics (TRDA)

P/S ratio as of January 2025 (TTM): 2.32

According to Entrada Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.18. At the end of 2024 the company had a P/S ratio of 2.84.

P/S ratio history for Entrada Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.84-27.15%
20233.90
2022N/A
2021N/A